New chemo timing aims to cut harsh side effects for GI cancer patients

This study tests a modified way of giving two chemotherapy drugs (capecitabine and oxaliplatin) to people with gastrointestinal cancers. The goal is to see if the new schedule causes fewer side effects, like nerve damage and low blood counts, compared to standard treatments. About 20 adults whose cancer is not curable but who need treatment for at least three months will take part. The study focuses on safety and how well patients tolerate the new schedule.